COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Trans-diagnostic Short-term Psychotherapy for Psychiatric Inpatients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04704973
Recruitment Status : Recruiting
First Posted : January 12, 2021
Last Update Posted : January 12, 2021
Stockholm University
Karolinska Institutet
Information provided by (Responsible Party):
Uppsala University

Brief Summary:
The project aims to investigate the effects of a short-term cbt-based psychotherapy intervention for a diagnostically mixed group of psychiatric inpatients. In a multiple baseline single subject design, 5-10 patients with mixed diagnoses that are treated at any of the inpatient units at the Hospital of Västmanland, Västerås, Sweden, will be offered a short psychotherapeutic intervention. The intervention is cbt based, and consists of focused functional analysis with identification of the main problem to be treated; an experiential exercise called the life line, in which obstacles to living a valued life are investigated, and in which alternative steps to be taken in spite of psychiatric symptoms are formulated; a summary excercise called the pause, in which central principles of the treatment are repeated, and in which a relapse prevention plan is formulated. The intervention will consist of approximately 2-5 sessions. The primary research question is whether such an intervention is effective in terms of causal change in problem areas identified as personally meaningful by the individual patient.

Condition or disease Intervention/treatment Phase
Psychiatric Disorder Behavioral: Transdiagnostic short-term psychotherapy Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: This is a single-case experimental design, with a multiple baseline across participants.
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Trans-diagnostic Short-term Psychotherapy for Psychiatric Inpatients
Actual Study Start Date : November 2, 2020
Estimated Primary Completion Date : June 30, 2021
Estimated Study Completion Date : December 31, 2021

Arm Intervention/treatment
Experimental: Transdiagnostic short-term psychotherapy Behavioral: Transdiagnostic short-term psychotherapy
Focused clinical functional analysis, formulation of a valued life direction includings strategies to handle obstacles, and a summarizing exercise including relapse prevention.

Primary Outcome Measures :
  1. Personal Questionnaire [ Time Frame: 2-3 times daily approximately 1-2 days prior to intervention, 2-3 times daily during intervention, and 2-3 times daily for 2-3 days after intervention. ]
    A numeric idiographic measure of change in individual presenting symptoms. 1-4 points, higher points reflecting worse outcome.

Secondary Outcome Measures :
  1. Bull's-Eye Values Survey [ Time Frame: 2-3 times daily approximately 1-2 days prior to intervention, 2-3 times daily during intervention, and 2-3 times daily for 2-3 days after intervention. ]
    A measure of change in values-based living. 0-28 points, higher points reflecting better outcome.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient treated at any of the inpatient wards at Hospital of Västmanland, Västerås, Sweden, with any diagnosis or combination of diagnoses.
  • Cognitive level such that informed consent can be given.
  • A stable baseline with regards to the chosen dependent variable.

Exclusion Criteria:

  • Other ongoing psychological treatment on the ward.
  • Cognitive deficits that prevent the giving of informed consent.
  • Unstable baseline.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04704973

Layout table for location contacts
Contact: Mårten Tyrberg, PhD +46721530033

Layout table for location information
Hospital of Västmanland, Västerås Recruiting
Västerås, Västmanland, Sweden, 72189
Contact: Mårten Tyrberg, PhD         
Sponsors and Collaborators
Uppsala University
Stockholm University
Karolinska Institutet
Layout table for investigator information
Study Chair: Kent Nilsson, PhD Uppsala University
Layout table for additonal information
Responsible Party: Uppsala University Identifier: NCT04704973    
Other Study ID Numbers: 2020-03251
First Posted: January 12, 2021    Key Record Dates
Last Update Posted: January 12, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Mental Disorders
Problem Behavior
Behavioral Symptoms